soluble amyloid-β (Aβ) is considered to be a critical component in the pathogenesis of Alzheimer's disease (AD). Evidence suggests that these non-fibrillar Aβ assemblies are implicated in synaptic dysfunction, neurodegeneration and cell death. However, characterization of these species comes mainly from studies in cellular or animal models, and there is little data in intact human samples due to the lack of adequate optical microscopic resolution to study these small structures. Here, to achieve super-resolution in all three dimensions, we applied Array Tomography (AT) and Stimulated Emission Depletion microscopy (STED), to characterize in postmortem human brain tissue non-fibrillar Aβ structures in amyloid plaques of cases with autosomal dominant and sporadic AD. Ultrathin sections scanned with super-resolution STED microscopy allowed the detection of small Aβ structures of the order of 100 nm. We reconstructed a whole human amyloid plaque and established that plaques are formed by a dense core of higher order Aβ species (~0.022 µm 3 ) and a peripheral halo of smaller Aβ structures (~0.003 µm 3 ). This work highlights the potential of AT-STED for human neuropathological studies.
The study of small structures such as non-fibrillar Aβ species in human brain samples has been challenging due to the limited resolution of immunohistochemistry using conventional microscopy. The lowest resolution obtained with optical microscopy is 200 nm, thus precluding any detailed characterization of those species. A recent study showed that the combination of new technologies such as focused ion beam milling and scanning electron microscopy (FIB/SEM) plus computational tools can be applied for the study of human amyloid plaques or synapses in the AD brain 40 . The use of hyperspectral Raman imaging has been also applied for the study of the biochemical components and β-sheet content of amyloid plaques and their surroundings 41 . In light microscopy, other techniques are also emerging for the study of small structures in brain tissue. One example is array tomography (AT), a technique that combines ultrathin sectioning of the tissue to increase the axial resolution with immunofluorescence, allowing quantitative analysis of high-resolution and large-field volumetric imaging of different specimens, such as synapses or pathological aggregates 42 . AT has demonstrated the ability to resolve Aβ synaptic deposits in AD brains 6 . Additionally, in the super-resolution (SR) fluorescence microscopy domain, Stimulated Emission Depletion (STED) microscopy is a technique that combines a high resolution confocal microscope with a high power donut-shaped depletion laser. The STED configuration uses the excitation and depletion lasers simultaneously increasing the lateral resolution by reducing the emission area selectively depleting the fluorescent molecules under the donut-shaped beam 43, 44 .
In the present work, we propose a new tool to study the nanometric neuropathology of neurodegenerative diseases by combining ultrathin sections used in AT scanned with super-resolution STED microscopy. Applying AT-STED, we investigate the nanoscale architecture of non-fibrillar Aβ structures in human amyloid plaques. We also investigated the load and size of these non-fibrillar Aβ entities in post-mortem human brain tissue in ADAD (PSEN1 mutation carriers) and early-onset sporadic AD (eoSAD) patients.
Results
Conventional immunohistochemistry reveals no differences between ADAD and eoSAD cases in total or non-fibrillar Aβ. We included a group of 14 patients with eoSAD, 10 patients with ADAD carrying a PSEN1 mutation and 9 healthy controls. Demographic, clinical and genetic data are shown in Supplementary  Table S1 . Detailed neuropathological data of the cases is shown in Supplementary Table S2 . As expected, eoSAD cases had a later age of onset and death and higher frequency of the APOEε4 allele compared to ADAD cases.
We employed conventional immunohistochemistry of consecutive sections to examine the differences in total and non-fibrillar Aβ immunoreactivity (using the NAB61 antibody) between ADAD, eoSAD and control cases. We found higher amyloid load in ADAD and eoSAD cases (p < 0.001) compared to controls but without differences between the AD groups ( Fig. 1 ).
Improving spatial and axial resolution with AT and STED. We next investigated the potential of combining two microscopy techniques to investigate non-fibrillar Aβ structures in human AD brains. AT provides improved resolution in the axial plane by obtaining 70 nm thick tissue sections. Due to the special fixation and tissue processing requirements for this method, the availability of samples for this type of studies is limited. In order to obtain nanometric resolution in the lateral directions here we combined AT with STED. STED microscopy combines a high resolution confocal microscope with a high power depletion laser. This laser has been engineered to obtain a donut-shaped focal-spot and it is scanned simultaneously with the excitation laser. This configuration enables stimulated depletion emission on the molecules under the donut-shaped beam. Thus, the emitted light in this outer region of the excitation beam is forced to emit at the wavelength of the STED laser. Using adequate spectral filtering, the light generated in the center of the donut is then collected for analysis which is determined by the power of the STED laser. We acquired images of amyloid-β plaques with an STED microscope using both confocal and STED configurations. The combination of AT and the settings of STED used in this experiment yielded a minimum effective voxel size of 70 × 100 × 100 nm. This voxel size allowed us to resolve smaller non-fibrillar Aβ structures in comparison with using AT alone ( Fig. 2) . A 3D reconstruction of a full amyloid β plaque of ~50 µm of diameter is shown in Fig. 2 . The use of AT-STED microscopy provided increased resolution of the amyloid-β aggregates compared with high resolution confocal microscopy. A tool published by Merino et al. 44 , enables to obtain an objective parameter, in which the sample is also considered, that can be used to determine the optimal settings for the STED image acquisition. Using this tool, we demonstrated an extension in the frequencies that allowed identifying objects down to 110 nm; in contrast, with AT alone the size of the smallest structure detected in the lateral plane was 220 nm.
ADAD and a SAD case. We stratified the objects depending on the presence of PSEN1 mutation and analyzed the distribution, size, proportion and quantity of non-fibrillar Aβ structures (total of ~18.000 objects). We observed an increase in the number of Aβ structures for all sizes (small, medium and large) in the ADAD case compared with the SAD case (p < 0.001) ( Fig. 5 ). 
Discussion
This study combines two microscopy techniques to examine non-fibrillar Aβ structures in human amyloid plaques in the brain. Using this enhanced resolution we demonstrate that the distribution of Aβ assemblies consists of a dense core of higher order Aβ species surrounded by a peripheral halo of small Aβ structures. The combination of AT and STED allowed detecting non-fibrillar Aβ forms of at least 100 nm. Finally, we provide preliminary evidence of higher levels of Aβ structures in an ADAD case compared to a SAD case.
Several studies have focused on the characterization of Aβ oligomers in AD 6,45-47 . Electrophysiological and biochemical experiments have suggested that soluble Aβ oligomers correlate with disease severity 48, 49 and that www.nature.com/scientificreports www.nature.com/scientificreports/ there is an inverse correlation between the size of Aβ assemblies and their toxicity in multiple in vitro and in vivo models 3,6,7 . The potential structure, size, conformation, aggregation and induction of neurotoxicity of Aβ oligomers in AD pathogenesis has been thoroughly investigated through the application of several advanced technologies such as ion mobility-based mass spectrometry 25 , atomic force microscopy 50,51 , solid-state nuclear magnetic resonance 52 and X-ray microdiffraction 53 . Other studies have used FIB/SEM to investigate the relationship between amyloid plaques and the synaptic organization in human AD brains 40 .
Here, we combined AT and STED to improve the resolution obtained with conventional confocal microscopy (x, y: 250 nm and z: 700 nm) and the detection of non-fibrillar Aβ structures in human amyloid plaques. AT achieves a resolution of 70 nm on the axial plane, while STED microscopy can increase the lateral resolution. In our case the addition of STED increased the lateral resolution up to 100 nm. This technique has been applied to investigate in detail the cellular mechanisms underlying dendritic spine plasticity 54, 55 , glial processes 56 or α-synuclein synaptic aggregation 57 among others. Using the enhanced resolution of AT-STED we were able to reconstruct a whole human amyloid plaque and examined in detail the nanoscale distribution and size of the non-fibrillar Aβ species. AT-STED allows detection of Aβ structures of at least 100 nm, an undetectable size range for immunohistochemical assays due to the resolution limit of light and confocal microscopes (~250 nm) 43, 58 . The study revealed that human amyloid plaques consist of a dense core of NAB61 large immunoreactive structures (~0.022 µm 3 ) and a peripheral halo of medium and small non-fibrillar Aβ entities (~0.01 µm 3 and ~0.003 µm 3 respectively). These results are in agreement with a study that used the AT technique to study NAB61 immunoreactivity in an animal model of AD 5 . However, we were able to detect non-fibrillar Aβ structures 2 times smaller using AT-STED in human tissue.
In addition, we show preliminary evidence that non-fibrillar Aβ structures were increased in an ADAD case compared to a SAD case in human brain tissue. It is known that oligomeric Aβ accumulation induces neuronal cell loss 27 , astrocytic dysfunction 59 and synaptic toxicity 6, 33 , and it is possible that higher levels of non-fibrillar Aβ are a characteristic of ADAD and may be the reflection of abnormal APP processing 17 . Interestingly, this result was not detectable in conventional immunoassays pointing out the importance of implementing super-resolution techniques for detailed neuropathological studies.
The strengths of this work are the inclusion of two microscopy techniques for the study of human brain samples; and the implementation of computational tools for image processing and analysis. The main limitations are the small sample size for AT-STED due to fact that the requirement of fresh tissue makes these samples extremely scarce. Second, we only used one antibody to detect non-fibrillar Aβ. However, in our hands specific antibodies for oligomeric Aβ suitable for human tissue are exceedingly rare and NAB61 has been extensively characterized 5, 33, 60 .
In conclusion, as a proof of concept our study shows that the combination of AT and STED can be successfully applied to investigate non-fibrillar Aβ structures in AD human brain. The obtained nanoscale architecture of human amyloid plaques reveals a dense core with a peripheral halo and we provide evidence of higher levels of non-fibrillar Aβ species in ADAD compared to SAD. Additional studies are needed to further investigate the potential relevance of these assemblies in the pathogenesis of the disease. This new tool proposed opens an important door for the neuropathology field allowing the characterization of aggregates or structures at a nanometric scale as potential therapeutic targets. www.nature.com/scientificreports www.nature.com/scientificreports/ Materials and Methods standard protocol approval and patient consent. We obtained written informed consent from all brain donors and/or next of kin for the use of brain tissue for research. The study was approved by the local ethics committee of Hospital de Sant Pau, Barcelona, Spain. All research was performed in accordance with relevant guidelines and regulations. postmortem human brain samples. Brain samples for immunohistochemical assays were provided by the Neurological Tissue Bank (NTB) of the Biobanc-Hospital Clínic-IDIBAPS and processed as previously described 61 and as internationally recommended 62 . The study group consisted of 34 subjects: 10 patients with PSEN1 mutations, 14 eoSAD patients with an age of onset <65 years and a group of 9 healthy controls. Fresh brain tissue from one ADAD (PSEN1 G206D, age 63) and one SAD case (age 90) was processed for AT as previously described 57, 63 and included in our collection. www.nature.com/scientificreports www.nature.com/scientificreports/ Immunohistochemistry, image acquisition and analysis. Immunohistochemistry was performed on 5-μm-thick consecutive sections of occipital cortex on an automated stainer (DAKO Autostainer Plus; DAKO, Glostrup, Denmark) using the following primary antibodies: mouse monoclonal anti-amyloid beta clone 6F/3D (dilution 1:400, DAKO, Glostrup, Denmark) and mouse anti-NAB61 (dilution 1:250, a kind gift from Virginia Lee, University of Pennsylvania, Philadelphia, USA). Reaction was visualized by the EnVision + system peroxidase procedure (DAKO, Glostrup, Denmark). Full-section scans were obtained with Pannoramic MIDI II (3DHistech, Budapest, Hungary) using a 40x objective. Cortical grey matter of each case was manually delimitated with pannoramic viewer software (3DHistech, Budapest, Hungary). An adaptation of the algorithm previously described 64 was developed to quantify total Aβ and NAB61 immunoreactivity with MATLAB software (The Math Works, Inc., Natick, MA, USA). Specifically, a colour deconvolution was used to split the channels and a mean local filter was then applied to segment the structures ( Supplementary Fig. S1 ).
Array tomography. Brain samples for AT were processed using previously described methods 57, 63 . Briefly, 70 nm-thick sections were obtained using an ultramicrotome (Leica Microsystems) equipped with an Ultra Jumbo Diamond Knife 35° (Diatome) from LR white embedded tissue blocks. The ribbons were stained as previously Figure 5 . Non-fibrillar Aβ structures are increased in an ADAD case. (A-F) Representative images of nonfibrillar Aβ structures distribution and size identified in plaques of an ADAD (n = 8) and a SAD (n = 5) case using AT-STED. Neurofilament light protein (magenta) was stained to visualize the neuronal distribution around the plaques. Scale bar = 10 µm and 1 µm for the inset. (G) ADAD and SAD distribution of NAB61 structures number by size. Differences were found between both distributions (p < 0.001). (H) All Aβ entities were significantly increased in ADAD compared to SAD case (p < 0.001).
